The global cell therapy manufacturing market is undergoing a transformative evolution, propelled by groundbreaking advances in regenerative medicine, increased clinical application of cell-based therapies, and expanding investment in advanced therapy medicinal products (ATMPs). Valued at USD 5.68 billion in 2024, the market is forecast to grow at a remarkable CAGR of...

In recent years the global gene delivery technologies market has entered a phase of sustained strategic transformation, and underlying this evolution is a powerful quantitative foundation: the gene delivery technologies market was valued at USD 5.42 billion in 2024 growing at a CAGR of 11.1% from 2025-2034. This trajectory is rooted in increasing clinical adoption of gene therapies, expansion...